Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT00872586
Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
304 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00856271
Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
287 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00107523
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
0 Enrollment(s)
2 Study location(s)
Interventional (Phase I)
Leukemia
Completed
NCT00385944
The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
56 Enrollment(s)
2 Study location(s)
Interventional (Phase II)
Acute Coronary Syndrome
Completed
NCT00097591
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
13,619 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Coronary Arteriosclerosis
Acute Coronary Syndromes
Completed
NCT00357968
Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting
201 Enrollment(s)
16 Study location(s)
Interventional (Phase II)
Coronary Artery Disease
Completed
NCT01109784
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
70 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Coronary Artery Disease (CAD)
Acute Coronary Syndrome (ACS)
Completed
NCT00654745
18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
207 Enrollment(s)
0 Study location(s)
Interventional (Phase IV)
Type 2 Diabetes
Hypertension